We are live on ! Find out more
IDXX icon

Idexx Laboratories

1,123 hedge funds and large institutions have $29.8B invested in Idexx Laboratories in 2024 Q4 according to their latest regulatory filings, with 165 funds opening new positions, 339 increasing their positions, 439 reducing their positions, and 141 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 165 | Existing positions closed: 141

1% more funds holding

Funds holding: 1,1151,123 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1212 (0)

1.33% less ownership

Funds ownership: 89.14%87.82% (-1.3%)

19% less capital invested

Capital invested by funds: $36.7B → $29.8B (-$6.98B)

23% less repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 439

44% less call options, than puts

Call options by funds: $71.7M | Put options by funds: $129M

Holders
1,123
Holders Change
+8
Holders Change %
+0.72%
% of All Funds
14.79%
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
165
Increased
339
Reduced
439
Closed
141
Calls
$71.7M
Puts
$129M
Net Calls
-$56.9M
Net Calls Change
+$24.1M
Name Holding Trade Value Shares
Change
Change in
Stake
PG
401
Patten Group
Tennessee
$2.4M -$353K -804 -12%
KIA
402
Knollwood Investment Advisory
Maryland
$2.4M
GLF
403
Groupe la Francaise
France
$2.4M +$2.55M +5,812 New
RVM
404
Robinson Value Management
Texas
$2.39M +$2.54M +5,787 New
MML Investors Services
405
MML Investors Services
Massachusetts
$2.38M -$2.9M -6,614 -53%
HT
406
Headlands Technologies
Illinois
$2.37M +$2.51M +5,721 New
LAM
407
LECAP Asset Management
United Kingdom
$2.36M +$2.14M +4,872 +588%
KRS
408
Kentucky Retirement Systems
Kentucky
$2.34M -$34.2K -78 -1%
CCA
409
Childress Capital Advisors
Texas
$2.34M -$55.3K -126 -2%
DC
410
Davenport & Co
Virginia
$2.34M +$579K +1,321 +30%
CWM
411
Cabot Wealth Management
Massachusetts
$2.32M -$43.9K -100 -2%
NB
412
Norinchukin Bank
Japan
$2.31M +$202K +460 +9%
KA
413
Kintegral Advisory
New York
$2.28M -$112K -256 -4%
ET
414
Entropy Technologies
New York
$2.27M +$991K +2,259 +70%
BBVA
415
Banco Bilbao Vizcaya Argentaria
Spain
$2.27M -$468K -1,067 -16%
JF
416
Jump Financial
Illinois
$2.27M +$1.59M +3,636 +196%
TC
417
TownSquare Capital
Utah
$2.26M +$184K +420 +8%
KIA
418
Kraematon Investment Advisors
Massachusetts
$2.26M -$48.2K -110 -2%
AWM
419
Apollon Wealth Management
South Carolina
$2.2M -$889K -2,027 -28%
M&T Bank
420
M&T Bank
New York
$2.18M -$181K -413 -7%
MGIA
421
Moneta Group Investment Advisors
Missouri
$2.18M -$14.5K -33 -0.6%
RWP
422
RWA Wealth Partners
Massachusetts
$2.17M -$21.9K -50 -0.9%
Cambridge Investment Research Advisors
423
Cambridge Investment Research Advisors
Iowa
$2.15M +$140K +320 +7%
TFCM
424
Taylor Frigon Capital Management
Arizona
$2.13M -$235K -536 -9%
HIMCH
425
Hartford Investment Management Co (HIMCO)
Connecticut
$2.09M -$51.8K -118 -2%

IDXX Hedge Fund Activity: Q4 2024 in Review

1,123 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2024, worth a combined $29.8B — down 19% from $36.7B a quarter earlier.

Buyers outnumbered sellers: 165 funds opened new IDXX positions and 141 closed out — a net gain of 24 holders — while 339 added to existing stakes and 439 trimmed.

The largest buyer was Flossbach Von Storch, adding an estimated $204M. The largest seller was AllianceBernstein, cutting an estimated $692M.

  • 1,123 institutional investors held Idexx Laboratories (IDXX) as of Q4 2024, up from 1,115 in Q3 2024.
  • Funds reported $29.8B of Idexx Laboratories stock for Q4 2024, down 19% quarter-over-quarter.
  • 165 funds opened new Idexx Laboratories positions in Q4 2024 and 141 closed out, a net change of +24 holders.
  • The largest Idexx Laboratories buyer in Q4 2024 was Flossbach Von Storch, an estimated $204M added.
  • The largest Idexx Laboratories seller in Q4 2024 was AllianceBernstein, an estimated $692M sold.

Based on aggregated 13F filings for Q4 2024.